Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Rio Tinto Plc. ( RIO - Analyst Report ) is set to report full year 2012 results on Feb 14. It reported dismal half year results earlier, with a year-over-year decrease in both revenue and earnings. Let’s see how things are shaping up for this announcement.
Growth Factors for the First Half 2012
Rio Tinto was badly affected by lower prices of most of the commodities in the first half 2012 along with a decline in demand among regions like China, Europe and the US. However, prices for gold, minerals and thermal coal saw a rise in the reported period. The company increased its iron ore production at the Pilbara ports and Rio Tinto Coal Australia. There was, however, a blow to Rio’s margins in the period due to an increase in the energy, fuel and diesel costs.
Earnings Whispers?
Our proven model does not conclusively show that Rio is likely to beat earnings this year. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank of #1, 2 or 3 for this to happen. That is not the case here as you will see below.
Positive Zacks ESP: That is because the Most Accurate estimate stands at $4.93 while the Zacks Consensus Estimate is higher at $5.47. That is a difference of -9.9%.
Zacks Rank #3 (Hold): Rio’s Zacks Rank #3 (Hold) lowers the predictive power of ESP because the Zacks #3 Rank when combined with a negative ESP makes surprise prediction difficult. We caution against stocks with Zacks #4 and #5 Ranks (Sell rated stocks) going into the earnings announcement, especially when the company is seeing a negative estimate revisions momentum.
Other Stocks to Consider
Here are some other companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
Cliffs Natural Resources Inc. ( CLF - Analyst Report ) , Earnings ESP of 10.9% and Zacks Rank #2 (Buy).
Silvercrest Mines Inc. ( SVLC - Snapshot Report ) , Earnings ESP of 22.2% and Zacks Rank #2 (Buy).
Phillips 66 ( PSX - Snapshot Report ) , Earnings ESP of 2.7% and Zacks Rank #2 (Buy).
Read the full reports :
Analyst Report on CLF
Analyst Report on RIO
Snapshot Report on PSX
Snapshot Report on SVLC